Mercia Fund Management has followed up on its first investment in 2015 with follow-on capital to Medherant Ltd. A total of £250,000 from both Mercia’s third-party University Growth Fund and Growth Fund 4 will allow Medherant to continue product development. Medherant has moved to new laboratories, and KEC professional Andrew Lee has been seconded from Warwick Ventures to the project.
Read more about Andrew's contribution in KEC Matters.
Further information about Mercia Fund Management's involvement with Medherant.